Perikardit & Perikardiyal Efüzyon

Giuseppe D., Ulrike K., Stephan K .,etc. Percutaneous left atrial appendage closure for cerebrovascular accident prevention: rationale, indications, technical aspects, clinical results and future perspective. Future Cardiol 2020 Jul;16(4):237-250. doi: 10.2217/fca-2019-0086.

Rebecca F., David R H., Krishnaswamy C., etc.The PROTECT AF (WATCHMAN Left Atrial Appendage System for Embolic PROTECTion in Patients with Atrial Fibrillation) trial. Am Heart Journal 2006 May;151(5):956-61. doi: 10.1016/j.ahj.2006.02.005.

Lakkireddy D, Thaler D, Ellis CR, etc. Amplatzer Amulet Left Atrial Appendage Occluder Versus WATCHMAN Device for Stroke Prophylaxis (Amulet IDE): A Randomized, Controlled Trial. Circulation. 2021;144:1543-52. doi:10.1161/CIRCULATIONAHA.121.057063

Guohua F., Bin H, Huimin C ., etc . Delayed pericardial effusion or tamponade following left atrial appendage closure: A single-center experience. Journal of the Formosan Medical Association . 2022 Nov 30;S0929-6646(22)00431-4 doi: 10.1016/j.jfma.2022.11.010.

David R.H.,Kasper K.,Josep R-C.,etc.Left atrial appendage occlusion .EuroIntervention 2023;18:e1038-e1065. DOI: 10.4244/EIJ-D-22-00627

Kavinsky CJ, Kusumoto FM, Bavry AA, et al.SCAI/ACC/HRS institutional and operatör requirements for left atrial appendage occlusion. Journal of the American College of Cardiology 2016;67:2295–305. doi: 10.1016/j.jacc.2015.12.001

Shuktika N., Purvi .,Tahmeed C.A Case of Delayed Hemorrhagic Effusive-Constrictive Pericarditis After Left Atrial Appendage Occlusion Device Placement. JACC Case Rep. 2019 Jun; 1(1): 27–31. doi: 10.1016/j.jaccas.2019.04.003

Khajali Z, Firouzi A, Pouraliakbar H,et.al. Case report of worsening of preexisting pericardial effusion after ASD device closure: is it calamitous? Egypt Heart Journal 2021;73(1):50. DOI: 10.1186/s43044-021-00171-8

Ali S.,Martin K.C.Ng.,Philip S.,Death from pulmonary artery erosion complicating implantation of percutaneous left atrial appendage occlusion device Heart Rhythm 2013 Dec;10(12):1810-1.doi: 10.1016/j.hrthm.2013.07.046.

Sven M.-W.,Nicolas M.,Marcus S.,et al. Percutaneous left atrial appendage closure: Technical aspects and prevention of periprocedural complications with the watchman device World Journal of Cardiology 2015 February 26; 7(2): 65-75, DOI: 10.4330/wjc.v7.i2.65

Anna S.,Dipayon R.,David L.,et.al, Left Atrial Appendage Occlusion Complicated by Appendage Perforation Rescued by Device Deployment. Journal of Investigate Medicine High Impact Case Report. 2018 Jan-Dec; 6: doi:10.1177/2324709618800108

Lucas V B.,Hueseyin I.,Stephan K.,et. al.Efficacy and safety of left atrial appendage closure with WATCHMAN in patients with or without contraindication to oral anticoagulation: 1-Year follow-up outcome data of the EWOLUTION trial.Heart Rhythm,2017 Sep;14(9):1302-1308. doi:10.1016/j.hrthm.2017.05.038.